Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Liothyronine Sodium Patent Expiration

Liothyronine Sodium was first introduced by King Pharmaceuticals Research And Development Llc in its drug Cytomel on Approved Prior to Jan 1, 1982. Another drug containing Liothyronine Sodium is Triostat. 11 different companies have introduced drugs containing Liothyronine Sodium.


About Veterinary Liothyronine Sodium

Liothyronine Sodium is used in a drug marketed by 1 company: Zoetis Inc.

Other drugs containing Liothyronine Sodium are: Cytobin tablets .

Liothyronine Sodium's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Liothyronine Sodium Generic API Manufacturers

Several generic applications have been filed for Liothyronine Sodium. The first generic version for Liothyronine Sodium was by Watson Laboratories Inc and was approved on Jan 25, 1982. And the latest generic version is by Biocon Pharma Inc and was approved on Feb 6, 2024.

Given below is the list of companies who have filed for Liothyronine Sodium generic, along with the locations of their manufacturing plants worldwide.